{
    "clinical_study": {
        "@rank": "129320", 
        "arm_group": [
            {
                "arm_group_label": "Orlistat 60 mg", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate efficacy of orlistat 60 mg compared to placebo on\n      weight loss and abdominal adiposity in obese adults treatment."
        }, 
        "brief_title": "Evaluation of Orlistat Versus Placebo for Adult Obesity Treatment", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed Informed Consent;\n\n          -  Adults Male and Female \u2265 18 years old and \u2264 60 years old;\n\n          -  Obesity (BMI \u2265 30kg/m2)\n\n          -  Stable weight (less than 5% variation on the last 3 months);\n\n        Exclusion Criteria:\n\n          -  Pregnancy and Lactation or women without effective contraception;\n\n          -  Relevant clinical diseases;\n\n          -  Obesity associated to genetic syndrome;\n\n          -  Patients with diabetes;\n\n          -  Psychiatric disorders;\n\n          -  Alimentary disorders;\n\n          -  Use of: anorectics, herbal weight loss and/or constipation and laxatives, in the past\n             30 days;\n\n          -  Patients using cyclosporine or amiodarone;\n\n          -  Patients with bowel disease;\n\n          -  Prior bariatric surgery;\n\n          -  Anemia;\n\n          -  Hemoglobinopathies and coagulopathy;\n\n          -  History of cancer in the past five years;\n\n          -  Use of corticosteroids, oral or injectable, in the last 30 days."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01755676", 
            "org_study_id": "ORL60EMS0511"
        }, 
        "intervention": [
            {
                "arm_group_label": "Orlistat 60 mg", 
                "description": "1 tablet 3 times a day", 
                "intervention_name": "Orlistat 60 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "1 tablet 3 times a day", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Orlistat"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 24, 2013", 
        "location": {
            "contact": {
                "email": "larissa.trama@ispem.com.br", 
                "last_name": "M\u00e1rcio A Pereira, MD", 
                "phone": "+55 12 39131789"
            }, 
            "facility": {
                "address": {
                    "city": "S\u00e3o Jos\u00e9 dos Campos", 
                    "country": "Brazil", 
                    "state": "S\u00e3o Paulo", 
                    "zip": "12.243-280"
                }, 
                "name": "Instituto S\u00e3o Jos\u00e9 dos Campos em Pesquisas M\u00e9dicas - ISPEM"
            }, 
            "investigator": {
                "last_name": "M\u00e1rcio A Pereira, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Study, Parallel, Double-blind, Multicenter for Evaluation of Efficacy of Orlistat 60 mg for Adult Obesity Treatment Compared to Placebo Treatment.", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Health Surveillance Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Efficacy of Orlistat 60 mg compared to placebo in obesity treatment based on weight loss and abdominal adiposity during 24 weeks.", 
            "safety_issue": "Yes", 
            "time_frame": "196 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01755676"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Adverse event incidence of orlistat 60mg when used for weight loss in adults", 
            "safety_issue": "Yes", 
            "time_frame": "196 days"
        }, 
        "source": "EMS", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "EMS", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}